Skip to main content
SpringerLink
Log in

How to Make Effective Evaluation of Psychotropic Drug Effects in People with Developmental Disabilities and Self-Injurious Behavior

  • Chapter
  • First Online:
Handbook of Crisis Intervention and Developmental Disabilities

Part of the book series: Issues in Clinical Child Psychology ((ICCP))

Abstract

This chapter covers the basic considerations necessary to make an effective evaluation of psychopharmacological and behavioral interventions for people with developmental disabilities (DD), with emphasis on self-injurious behavior (SIB), a particularly difficult behavior problem. It is written for the evidence-based clinical researcher and practitioner who encounters these cases frequently. In it we cover a host of issues affecting outcomes: theoretical orientation of the practitioners, design and analysis issues, especially those relevant to the DD population, common pharmacological issues, common behavioral evaluation issues, political and funding issues, and helpful resource materials. Treatment of the topics is slanted toward the behavior analytic approach, since that is the one most commonly used with SIB; but this chapter is also relevant to other approaches and to other populations with DD besides the SIB population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aman, M. G., Bensen, B. A., Farmer, C. A., Hall, K., & Malone, K. (2007). Project MED: Effects of a medication education booklet series for individuals with intellectual Handicaps. Intellectual and Developmental Disabilities, 45, 33–45.

    Article  PubMed  Google Scholar 

  • Aman, M. G., Hollway, J. A., McDougle, C. J., Scahill, L., Tierney, E., McCracken, J. T., et al. (2008). Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology, 18, 227–236.

    Article  PubMed  Google Scholar 

  • Aman, M. G., McDougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., et al. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1143–1154.

    Article  PubMed  Google Scholar 

  • Aman, M. G., Singh, N., Stewart, A. W., & Field, C. J. (1985). The Aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal on Mental Deficiency, 89, 485–491.

    Google Scholar 

  • Aman, M. G., & Wolford, P. L. (1995). Consumer satisfaction in drug research: A social validity study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 940–945.

    Article  PubMed  Google Scholar 

  • Barlow, D. H., Nock, M. K., & Hersen, M. (2008). Single case experimental designs: Strategies for behavior change. Boston: Allyn & Bacon.

    Google Scholar 

  • Birnbrauer, J. S., Peterson, C. R., & Solnick, J. V. (1974). Design and interpretation of studies of single subjects. American Journal of Mental Deficiency, 79, 191–203.

    PubMed  Google Scholar 

  • Branch, M. N. (1984). Rate dependency, behavioral mechanisms, and behavior pharmacology. Journal of the Experimental Analysis of Behavior, 42, 28–38.

    Article  Google Scholar 

  • Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., et al. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17, 640–655.

    Article  PubMed  Google Scholar 

  • Chassan, J. B. (1976). Research design in clinical psychology and psychiatry. New York: Irvington.

    Google Scholar 

  • Chen, G. L., Novak, M. A., Meyer, J. S., Kelly, B. J., Vallendar, E. J., & Miller, J. S. (2010). TPH2 5′- and 3′-regulatory polymorphisms are differentially associated with HPA axis function and self-injurious behavior in rhesus monkeys. Genes, Brain, and Behavior, 1, 1–13.

    Google Scholar 

  • Cheng-Shannon, J., McGough, J. J., Pataki, C., & McCracken, J. T. (2004). Second-generation antipsychotic medications in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 14, 372–394.

    Article  PubMed  Google Scholar 

  • Courtemanche, A. B., Schroeder, S. R., & Sheldon, J. B. (2011). Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual developmental disabilities. American Journal on Intellectual and Developmental Disabilities, 116, 315–328.

    Article  PubMed  Google Scholar 

  • Courtemanche, A. B., Schroeder, S. R., Sheldon, J. B., Sherman, J. A., & Fowler, A. R. (2012). Observing signs of pain in relation to self-injurious behavior among individuals with intellectual and developmental disabilities. Journal of Intellectual Disability Research., 56, 501–515.

    Article  PubMed  Google Scholar 

  • Crosland, K. A., Zarcone, J. R., Lindauer, S. E., Valdovinos, M. G., Zarcone, T. J., Hellings, J. A., et al. (2003). Use of functional analysis methodology in the evaluation of medication effects. Journal of Autism and Developmental Disorders, 33, 271–279.

    Article  PubMed  Google Scholar 

  • De Leon, J., Greenlee, J. B., Sabaawi, M., & Singh, N. (2009). Practical guidelines for use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities. Research in Developmental Disabilities, 30, 613–669.

    Article  PubMed  Google Scholar 

  • Dicesare, A., McAdam, D. B., Toner, A., & Varell, J. (2005). The effects of methylphenidate on a functional analysis of disruptive behavior: A replication and extension. Journal of Applied Behavior Analysis, 38, 125–128.

    Article  PubMed  Google Scholar 

  • Fabiano, G. A., Pelham, W. E., Gnagy, E. M., MacLean, L. B., Coles, E. K., Chacko, A., et al. (2007). The single and combined effects of multiple intensities of behavior modification and methylphenidate for children with attention deficit hyperactivity disorder in a classroom setting. School Psychology Review, 36, 195–216.

    Google Scholar 

  • Getz, k., & Sisson, S. (2003). Clinical grant market decelerates. Center Watch, 10, 4–5.

    Google Scholar 

  • Gualtieri, C. T., Schroeder, S. R., Hicks, R. E., & Quade, D. (1986). Tardive dyskinesia in young mentally retarded individuals. Archives of General psychiatry, 43, 335–340.

    Article  PubMed  Google Scholar 

  • Guy, W. (1976). Clinical global impressions scale. ECDEU Assessment: Manual for psychopharmacology (revised edition) US Dept. of Health, Education, and Welfare, Publication (ADM 76–338) (pp. 217–222). Rockville, MD.

    Google Scholar 

  • Hastings, R. P. (2002). Do challenging behaviors affect staff psychological well-being? Issues of causality and mechanism. American Journal on Mental Retardation, 107, 455–467.

    Article  PubMed  Google Scholar 

  • Hellings, J. A. (1999). Psychopharmacology of mood disorders in persons with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5, 270–278.

    Article  Google Scholar 

  • Hellings, J. A., Zarcone, J. R., Reese, R. M., Valdovinos, M. G., Marquis, J., Fleming, K. K., et al. (2006). A crossover study of children adolescents, and adults with mental retardation. Journal of Autism and Developmental Disorders, 36, 401–411.

    Article  PubMed  Google Scholar 

  • Higgins, J., & Green, S. (2006). Cochrane handbook for systematic reviews of interventions 4.2.6. The Cochrane Library (Vol. 4). Chichester, UK: Wiley.

    Google Scholar 

  • Iwata, B., Dorsey, M., Slifer, K., Bauman, K., & Richman, G. (1982). Toward a functional analysis of self-injury. Analysis and Intervention in Developmental Disabilities, 2, 3–20.

    Article  Google Scholar 

  • Iwata, B. A., Pace, G. M., Kissel, R. C., Nau, P. A., & Farber, J. M. (1990). The self-injury trauma (SIT) scale: A method for quantifying surface tissue damage caused by self-injurious behavior. Journal of Applied Behavior Analysis, 23, 99–110.

    Article  PubMed  Google Scholar 

  • Johnson, C. R., Handen, B. L., Butter, E., Wagner, A., Mulick, J., Sukhodolsky, D. G., et al. (2007). Development of a parent training program for children with pervasive developmental disorders. Behavior Intervention, 22, 201–221.

    Article  Google Scholar 

  • Johnston, J. M., & Pennypacker, H. S. (2009). Strategies and tactics of behavioral research (3rd ed.). New York: Routledge.

    Google Scholar 

  • Kahng, S., Iwata, B. A., & Lewin, A. B. (2002). Behavioral treatment of self-injury, 1964 to 2000. American Journal on Mental Retardation, 107, 212–221.

    Article  PubMed  Google Scholar 

  • Kazdin, A. E. (1977). Assessing the clinical or applied importance of behavior change through social validation. Behavior Modification, 1, 427–452.

    Article  Google Scholar 

  • Lesch, M., & Nyhan, W. L. (1964). A familial disorder of uric acid metabolism and central nervous system function. American Journal of Medicine, 36, 561–570.

    Article  PubMed  Google Scholar 

  • Lewis, M. H., & Kim, S. J. (2009). The pathophysiology of restricted repetitive behavior. Journal of Neurodevelopmental Disorders, 1, 114–132.

    Article  PubMed  Google Scholar 

  • Lloyd, T., & Hastings, R. P. (2008). Psychological variables as correlates of adjustment in mothers of children with intellectual disabilities: Cross-sectional and longitudinal relationships. Journal of Intellectual Disability Research, 52, 37–48.

    PubMed  Google Scholar 

  • Matson, J. L. (1998). Matson evaluation of drug side-effects (MEDS). Baton rouge, LA: Disability Consultants, LLC.

    Google Scholar 

  • Matson, J. L. (Ed.). (2007). Handbook of assessment in persons with intellectual disability. International Review of Research in Mental Retardation. (Vol. 34). New York: Elsevier.

    Google Scholar 

  • Matson, J. L., & Neal, D. (2009). Psychotropic medication use for challenging behaviors in person with intellectual disabilities: An overview. Research in Developmental Disabilities, 30, 572–586.

    Article  PubMed  Google Scholar 

  • Mayhew, M. (2005). Off-label prescribing. Journal of Nurse Practitioners, 5, 122–123.

    Article  Google Scholar 

  • Mayo, L., Oyama, R., LeBlanc, J., Schroeder, S. R., Brady, N., Butler, M. G., et al. (2012). Mass screening for severe behavior problems among infants and toddlers in Peru. Journal of Metnal Health Research in Intellectual Disabilities, 5(3–4), 246–259.

    Article  Google Scholar 

  • McAdam, D. B., Zarcone, J. R., Hellings, J. A., Napolitano, D. A., & Schroeder, S. R. (2002). Effects of risperidone on aberrant behavior in persons with developmental disabilities. II. Social validity measures. American Journal on Mental Retardation, 107, 261–269.

    Article  PubMed  Google Scholar 

  • McCannell, K. L., & Duff, H. J. (1995). Drug development, the evaluation of new drugs, and principles of therapeutics. In P. L. Munson, R. A. Mueller, & G. R. Breese (Eds.), Textbook of pharmacology (pp. 75–84). New York: Chapman and Hall.

    Google Scholar 

  • Napolitano, D. A., Jack, S. L., Sheldon, J. B., Williams, M. A., et al. (1995). Drug-behavior interactions in persons with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5, 322–334.

    Article  Google Scholar 

  • Nathan, P. E., & Gorman, J. M. (2003). A guide to treatments that work (Vol. 2). New York: Oxford University Press.

    Google Scholar 

  • National Institute of Health. (Ed.). (1991). Treatment of destructive behaviors in persons with developmental disabilities (pp. 125–171) (NIH Publication No. 91–2410). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Noone, S. J., & Hastings, R. P. (2011). Values and social acceptance as correlates of burnout in support staff working with intellectual disabilities. Journal of Mental Health Research in Intellectual Disabilities, 4, 79–89.

    Article  Google Scholar 

  • O’Leary, K. D., & Borkovec, T. D. (1978). Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research. American Psychologist, 33, 821–830.

    Article  PubMed  Google Scholar 

  • Poling, A., & LaSage, M. (1995). Applied behavior analysis, social validation, and the psychopharmacology of mental retardation. Mental Retardation and Developmental Disabilities Research Reviews, 5, 342–347.

    Article  Google Scholar 

  • Rasaratnam, R., Crouch, K., & Regan, A. (2004). Attitude to medication of parents/primary carers of people with intellectual disability. Journal of Intellectual Disability Research, 48, 754–763.

    Article  PubMed  Google Scholar 

  • Reiss, S., & Aman, M. G. (Eds.). (1998). Psychotropic medications and developmental disabilities: The international consensus handbook. Columbus OH: The Ohio State University.

    Google Scholar 

  • Rickels, K., Lipman, R., Fisher, S., Park, L. C., & Uhlenhuth, E. H. (1970). Is a double—Blind clinical trial really blind? A report of doctors’ medication guesses. Psychopharmacologia, 16, 329–336.

    Article  PubMed  Google Scholar 

  • Rojahn, J. (1994). Epidemiology and topographic taxonomy of self-injurious behavior. In T. Thompson & D. Gray (Eds.), Destructive behavior and developmental disabilities (pp. 49–67). Thousand Oaks, CA: Sage Publications.

    Google Scholar 

  • Rojahn, J., & Esbensen, A. (2002). Epidemiology of self-injurious behavior in mental retardation. In S. Schroeder, M. L. Oster-Granite, & T. Thompson (Eds.), Self-injurious behavior: Gene-brain-behavior relationships (pp. 41–77). Washington, DC: APA Books.

    Chapter  Google Scholar 

  • Rojahn, J., Matson, J. L., Lott, D., Esbensen, A., & Smalls, Y. (2001). The Behavior Problems Inventory: An instrument for assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities. Journal of Autism and Developmental Disorders, 31, 21–33.

    Article  Google Scholar 

  • Rojahn, J., Rowe, E. W., Sharber, A. C., Hastings, R., Matson, J. L., Didden, R., et al. (2012). The behavior problems inventory-short form (BPI-S) for individuals with disabilities I: Development and clinical norms. Journal of Intellectual Disability Research, 56(5), 527–45.

    Article  PubMed  Google Scholar 

  • Rojahn, J., Schroeder, S. R., & Hoch, T. A. (2008). Self-injurious behavior in intellectual disabilities. Amsterdam: Elsevier.

    Google Scholar 

  • Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, J. K., Marvin, A. R., & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008. Journal of Autism and Developmental Disorders, 40, 342–351.

    Article  PubMed  Google Scholar 

  • Rush, A. J., & Frances, A. (2000). Expert consensus guidelines: Treatment of psychiatric and behavioral problems in mental retardation. American Journal on Mental Retardation, 104, 159–228.

    Google Scholar 

  • Sandman, C. A., Hetrick, W. P., Taylor, D., Barron, J. L., Touchette, P., Lott, I., et al. (1993). Naltrexone reduces self-injury and improves learning. Experimental and Clinical Psychopharmacology, 1, 242–258.

    Article  Google Scholar 

  • Sandman, C. A., Hetrick, W., Taylor, D. V., & Chicz-Demet, A. (1997). Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. American Journal on Mental Retardation, 102, 182–199.

    Article  PubMed  Google Scholar 

  • Sandman, C. A., Touchette, P. E., Marion, S. D., & Chicz-Demet, A. (2008). The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Developmental Psychobiology, 50, 680–689.

    Article  PubMed  Google Scholar 

  • Scahill, L., Aman, M. G., McCracken, J. T., McDougle, C. J., & Vitiello, B. (2008). Beware of over-interpreting negative trials. Journal of Autism and Developmental Disorders, 38, 1609–1610.

    Article  PubMed  Google Scholar 

  • Scahill, L., Aman, M. G., McDougle, C. L., Arnold, L. E., McKracken, J. T., Handen, B., et al. (2009). Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autismand Developmental Disorders, 39, 720–729.

    Article  Google Scholar 

  • Schroeder, S. R., & Courtemanche, A. B. (2012). Early prevention of severe neurodevelopemental behavior disorders: An integration. Journal of Mental Health Research in Intellectual Disabilities, 5, 203–214.

    Article  PubMed  Google Scholar 

  • Schroeder, S. R., Kanoy, R. C., Mulick, J. A., Rojahn, J., Thios, S. J., Stephens, M., et al. (1982). Environmental antecedents which affect management and maintenance of programs for self-injurious behavior. In J. Hollis & C. E. Meyers (Eds.), Life-threatening behavior: Analysis and intervention (pp. 105–159). Washington, DC: AAMD.

    Google Scholar 

  • Schroeder, S. R., Lewis, M. H., & Lipton, M. A. (1983). Interaction of pharmacotherapy and behavior therapy among people with learning and behavior disorders. In K. Gadow, I. Bialer (Eds.), Advances in learning and behavioral disabilities (Vol. 2, pp. 179–225). Greenich, CT:JAI Press

    Google Scholar 

  • Schroeder, S. R., Loupe, P. S., & Tessel, R. E. (2008). Animal models of self-injurious behavior: Induction, prevention, and recovery. In L. M. Glidden (Ed.), International review of research in mental retardation (Vol. 35). London: Elsevier.

    Google Scholar 

  • Schroeder, S. R., Oster-Granite, M. L., & Thompson, T. (Eds.). (2002). Self-injurious: Gene-brain-behavior relationships. Washington, DC: APA Books.

    Google Scholar 

  • Schroeder, S. R., Rojahn, J., & Reese, R. M. (1997). Reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation. Journal of Autism and Developmental Disorders, 27, 89–102.

    Article  PubMed  Google Scholar 

  • Schroeder, S. R., Schroeder, C. S., Smith, B., & Dalldorf, J. (1978). Prevalence of self-injurious behavior in a large State facility for the retarded: A three-year follow-up study. Journal of Autism and Childhood Schizophrenia, 8, 261–270.

    Article  PubMed  Google Scholar 

  • Sidman, M. (1960). Tactics of scientific research. New York: Basic Books.

    Google Scholar 

  • Singh, N., Wahler, R., Sabaawi, M., Goza, A. B., Singh, A., Molina, E. J., et al. (2002). Mentoring treatment teams to integrate behavioral and psychopharmacological treatments in developmental disabilities. Research in Developmental Disabilities, 23, 379–389.

    Article  PubMed  Google Scholar 

  • Sleister, H. M., & Valdovinos, M. G. (2011). Why research on the pharmacogenetics of atypical antipsychotic-induced weight gain in individuals with intellectual disabilities in warranted. Journal of Mental Health Research in Intellectual Disabilities, 4, 65–78.

    Article  Google Scholar 

  • Sprague, R. L., & Werry, J. L. (1971). Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.), International review of research in mental retardation (Vol. 5, pp. 147–219). New York: Academic Press

    Google Scholar 

  • Symons, F. J., Harper, V. N., McGrath, P. J., Breau, L. M., & Bodfish, J. W. (2009). Evidence of increased non-verbal signs of pain in adults with Neurodevelopmental disorders and self-injury. Research in Developmental Disabilities, 30, 521–528.

    Article  PubMed  Google Scholar 

  • Symons, F. J., Thompson, A., & Rodriguez, M. C. (2004). Self-injury and the efficacy of naltrexone treatment: A quantitative synthesis. Mental Retardation and Developmental Disabilities Research Reviews, 10, 193–200.

    Article  PubMed  Google Scholar 

  • Tamminga, C. A. (2011). Editorial: When is polypharmacy an advantage? American Journal of Psychiatry, 168, 663–664.

    Article  PubMed  Google Scholar 

  • Taylor, L., Oliver, C., & Murphy, G. (2011). The chronicity of self-injurious behavior: A long-term follow-up of a total population. Journal of Applied Research in Intellectual Disability., 24, 105–117.

    Article  Google Scholar 

  • Thompson, T., Hackenberg, T., Cerutti, D., Baker, D., & Axtell, S. (1994). Opioid antagonist effects on self-injury in adults with mental retardation: Response form and location as determinants of medication effects. American Journal on Mental Retardation, 99, 85–102.

    PubMed  Google Scholar 

  • Tiefenbacher, S., Novak, M. A., Lutz, C. K., & Meyer, J. S. (2005). The physiology and neurochemistry of self-injurious behavior: A nonhuman primate model. Frontiers in Bioscience, 10, 1–11.

    Article  PubMed  Google Scholar 

  • Tierney, E., Aman, M. G., Stout, R., Pappas, K., Arnold, L. E., Vitiello, B., et al. (2007). Parent satisfaction in a multi-site acute trial of risperidone in children with autism: A social validity study. Psychopharmacology, 191, 149–157.

    Article  PubMed  Google Scholar 

  • Tunis, S. R., Stryer, D. B., & Clancy, C. M. (2003). Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association, 290, 1624–1632.

    Article  PubMed  Google Scholar 

  • Tyrer, P., Oliver-Africano, P. C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., et al. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behavior in patients with intellectual disability: A randomized controlled trial. Lancet, 371, 57–63.

    Article  PubMed  Google Scholar 

  • Unwin, G. L., & Deb, S. (2008). Use of medication for the management of behavior problems among adults with intellectual disabilities: A clinicians’ survey. American Journal on Mental Retardation, 113, 19–31.

    Article  PubMed  Google Scholar 

  • Unwin, G. L., & Deb, S. (2010). The use of medication to manage behaviour problems in adults with intellectual disability: A national guideline. Advances in Mental Health and Intellectual Disabilities, 4, 4–11.

    Article  Google Scholar 

  • Valdovinos, M. G., Napolitano, D. A., Zarcone, J. R., Hellings, J. A., Williams, D. C., & Schroeder, S. R. (2002). Multimodal evaluation of risperidone for destructive behavior: Functional analysis, direct observations, rating scales, and psychiatric impressions. Experimental and Clinical Psychopharmacology, 10, 268–275.

    Article  PubMed  Google Scholar 

  • Valdovinos, M. G., Nelson, S. M., Kuhle, J. L., & Dierks, A. M. (2009). Using analogue functional analysis to measure variations in problem behavior rate and function after psychotropic medication changes: A clinical demonstration. Journal of Mental Health Research in Intellectual Disabilities, 2, 279–293.

    Article  Google Scholar 

  • Valdovinos, M. G., Schroeder, S. R., & Kim, G. (2003). Prevalence of psychotropic medication use among adults with developmental disabilities: 1970–2000. In L. M. Glidden (Ed.), International review of research in mental retardation (Vol. 26, pp. 176–220). New York: Academic.

    Google Scholar 

  • Van Praag, H. M., Asnis, G. M., Kahn, R. S., Brown, S. L., Korn, M., et al. (1990). Monoamines and abnormal behavior. British Journal of Psychiatry, 157, 723–734.

    Article  PubMed  Google Scholar 

  • Ventola, C. L. (2009). Off-label information: Regulation, distribution, evaluation, and related controversies. Pharmacy and Therapeutics, 34, 428–432.

    PubMed  Google Scholar 

  • Vitiello, B., Aman, M. G., Scahill, L., McCracken, J. T., McDougle, C. J., Tierney, E., et al. (2005). Research knowledge among parents of children participating in a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 145–1149.

    Article  PubMed  Google Scholar 

  • Vollmer, T. R., & Matson, J. L. (1995). Questions about behavior functions. Baton Rouge, LA: Scientific Publishers, Inc.

    Google Scholar 

  • Weeden, M., Ehrhardt, K., & Poling, A. (2010). Psychotropic drug treatments for people with autism and other developmental disorders: A primer for practicing behavior analysts. Behavior Analysis in Practice, 3, 4–12.

    PubMed  Google Scholar 

  • Williams, D. C., & Saunders, K. J. (1997). Methodological issues in the study of drug effects on cognitive skills. In N. W. Bray (Ed.), International review of research in mental retardation (Vol. 21, pp. 147–185). New York: Academic.

    Chapter  Google Scholar 

  • Wolf, M. M. (1978). Social validity: The case for subjective measurement or how applied behavior analysis is finding its heart. Journal of Applied Behavior Analysis, 11, 203–214.

    Article  PubMed  Google Scholar 

  • Yoo, J. H., Williams, D. C., Napolitano, D. A., Peyton, R. T., Baer, D. M., & Schroeder, S. R. (2003). Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation. Journal of Applied Behavior Analysis, 36, 245–248.

    Article  PubMed  Google Scholar 

  • Zarcone, J. R., Hellings, J. A., Crandall, C., Reese, R. M., Marquis, J., Fleming, K., et al. (2001). Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. American Journal on Mental Retardation, 106, 525–538.

    Article  PubMed  Google Scholar 

  • Zarcone, J. R., Lindauer, S. E., Morse, P. S., Crosland, K. A., Valdovinos, M. G., McKerchar, T. L., et al. (2004). Effects of risperidone on destructive behavior of persons with developmental disabilities III. Functional analysis. American Journal on Mental Retardation, 109, 310–321.

    Article  PubMed  Google Scholar 

  • Zarcone, J. R., Napolitano, D., & Valdovinos, M. (2008). Measurement of problem behavior during medication evaluations. Journal of Disability Research, 52, 1015–1028.

    Article  Google Scholar 

Download references

Acknowledgements

NIH grants Nos. HD 060500, HD02528, HD 026927.

Author information

Authors and Affiliations

  1. University of Kansas, Lawrence, KS, USA

    Stephen R. Schroeder, Jessica A. Hellings & Andrea B. Courtemanche

Authors
  1. Stephen R. Schroeder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica A. Hellings
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea B. Courtemanche
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen R. Schroeder .

Editor information

Editors and Affiliations

  1. , Dept. Applied Behavioral Science, University of Kansas, Sunnyside Avenue 1000, Lawrence, 66045, Kansas, USA

    Derek D. Reed

  2. , Dept. Applied Behavioral Science, University of Kansas, Sunnyside Avenue 1000, Lawrence, 66044, Kansas, USA

    Florence D. DiGennaro Reed

  3. May Institute, Pacella Park Drive 41, Randolph, 02368, Massachusetts, USA

    James K. Luiselli

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schroeder, S.R., Hellings, J.A., Courtemanche, A.B. (2013). How to Make Effective Evaluation of Psychotropic Drug Effects in People with Developmental Disabilities and Self-Injurious Behavior. In: Reed, D., DiGennaro Reed, F., Luiselli, J. (eds) Handbook of Crisis Intervention and Developmental Disabilities. Issues in Clinical Child Psychology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6531-7_17

Download citation

Publish with us

Policies and ethics

Search

Navigation